by: People
by: TheWrap
CE Oof Europes Largest Publisher Mandates AI Usein Newsrooms You Only Haveto Explainif You Didnt
by: ThePrint
Maharashtra Launches Science and Innovation Activity Centres (SIACs) Honoring Dr. Jayant Narlikar
by: The Independent
Oxford University Faces Scrutiny Over Ties to China and Journal Censorship Concerns
by: People
Bellamy Youngand Fay Masterson Are Big Science Nerds. So They Co- Wrotea Sci- Fi Novel Exclusive
by: Observer
A Troveof Early Computer Art Is Hidingin Plain Sightin Sothebys Historyof Science Technology Sale
Four Keys To Successfully Launching AI In Life Sciences
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and deliver real outcomes.

Introduction to AI in Life Sciences
The Forbes article by Chase Feiger explores the transformative potential of artificial intelligence (AI) in the life sciences sector, an industry encompassing pharmaceuticals, biotechnology, and medical research. AI is increasingly seen as a game-changer in this field, offering opportunities to accelerate drug discovery, optimize clinical trials, personalize medicine, and improve operational efficiencies. However, integrating AI into life sciences is not without challenges, as the sector is heavily regulated, data-intensive, and reliant on precision and trust. Feiger outlines four critical strategies—or "keys"—that organizations must adopt to successfully implement AI initiatives in this complex environment. These keys are designed to address both the technical and cultural hurdles that often impede AI adoption, ensuring that companies can harness the technology's full potential while mitigating risks.
The life sciences industry stands at a pivotal moment where the convergence of vast datasets, advanced computational power, and AI algorithms can revolutionize how healthcare solutions are developed and delivered. From identifying novel drug targets to predicting patient outcomes, AI promises to reduce costs and timelines that have historically plagued the industry. For instance, traditional drug discovery can take over a decade and cost billions of dollars, with a high failure rate. AI, through machine learning and predictive analytics, can analyze massive datasets to identify promising compounds in a fraction of the time. Yet, as Feiger emphasizes, the path to successful AI integration is fraught with obstacles, including data silos, regulatory compliance, and skepticism from stakeholders. The four keys he presents serve as a roadmap for navigating these challenges.
Read the Full Forbes Article at:
https://www.forbes.com/sites/chasefeiger/2025/07/09/four-keys-to-successfully-launching-ai-in-life-sciences/
on: Wed, Jan 01st 2025
by: CIO
It's 2025. Are your data strategies strong enough to de-risk AI adoption?
on: Tue, Feb 18th 2025
by: FedScoop
Chief AI officers must be preserved in the Trump administration
on: Wed, Jun 18th 2025
by: Forbes
on: Fri, Jun 13th 2025
by: Forbes
The Digital Revolution: Unlocking The Power Of Data In Life Sciences
on: Mon, May 05th 2025
by: Seeking Alpha
Wiley inks pact with AWS to integrate scientific content into life sciences AI agents (WLY:NYSE)
on: Mon, Mar 31st 2025
by: Forbes
Mission First: Pharma Should Partner, Not Build, Their AI Solutions
on: Tue, Feb 11th 2025
by: Forbes
AI Agents Are Here: How Businesses Must Adapt To Stay Competitive
on: Tue, Jan 21st 2025
by: MSN
on: Fri, Jan 17th 2025
by: Wired
Harnessing AI and data science to discover life-changing medicines at AstraZeneca
on: Sun, Jan 12th 2025
by: MSN
on: Tue, Dec 03rd 2024
by: Tim Hastings
on: Tue, Jun 24th 2025
by: Forbes
Dear Life Sciences: Meet AI-Native Search, Your Missing Link